Dark Forest Capital Management LP Tg Therapeutics, Inc. Transaction History

Dark Forest Capital Management LP

  • $718 Million
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$13.32 - $19.19 $549,476 - $791,625
41,252 New
41,252 $733,000
Q3 2023

Nov 13, 2023
BUY
$8.36 - $26.5 $959,736 - $3.04 Million
114,801 Added 198.36%
172,675 $1.44 Million
Q2 2023

Aug 14, 2023
BUY
$15.48 - $35.0 $655,779 - $1.48 Million
42,363 Added 273.12%
57,874 $1.44 Million
Q1 2023

May 12, 2023
BUY
$10.23 - $19.34 $158,677 - $299,982
15,511 New
15,511 $233,000
Q1 2022

May 13, 2022
SELL
$7.81 - $20.45 $2,866 - $7,505
-367 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$15.2 - $35.51 $5,578 - $13,032
367 New
367 $7,000

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
88.3M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email